5Quinin M, Angelico MC, Warram JH’et al. Familial factorsdetermine the development of diabetic nephropathy in patients with ID-DM. Diabetologia 1996;39:940 - 945.
6Viberti GC,Keen H,Niseman MJ. Raised arterial pressure inparents of proteinuric insulin dependent diabetics. BMJ 1987 ; 295 :515 -517.
7Vlassara H,Striker LJ,telchberg S,et al. Advanced glycatianend products induce glomerular sclerosis and albuminuria in normalrats. Proc Natl Acad Sci USA 1994;91 : 11704 - 11708.
8The Diabetes Control and Complications Trial ResearchGroup. The effect of intensive treatment of diabetes on the derelopmentand Progression of longterm complications in insuliu-dependent diabe-tes mellitus. N Engl J Med 1993;329:977 - 986.
9UK Prospective Diabetes Study ( UKPDS) Group. Intensiveblood glucose control with sulphonylureas or insulin compared withconven tional treatment and risk of complications in patients with type2 diabetes (UKPDS 33).Lencet 1998;352:837 -853.
10Virchow R. Amore precise account of fatty metamorphosis in:Cellular Patlology as Based upon Physiological and Pathalogical His-tology (Transl chonce F) ,2nd Ed. London, J Chruchill 1860:342 -366.
二级参考文献5
1. A common mutation of the methylenetetrahydrofolate reductase gene as a risk factor for diabetic nephropathy[J] 1999,Diabetologia(5):631～632
2A. Chico,A. Pérez,A. Córdoba,R. Arcelús,G. Carreras,A. de Leiva,F. González-Sastre,F. Blanco-Vaca. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?[J] 1998,Diabetologia(6):684～693
3R. S. Newfield,M. Polak,R. Marchase,P. Czernichow. Epidemiology and genetics of diabetic complications[J] 1997,Diabetologia(3):B62～B64
4J. B. Ubbink,A. Merwe,W. J. H. Vermaak,R. Delport. Hyperhomocysteinemia and the response to vitamin supplementation[J] 1993,The Clinical Investigator(12):993～998
